Mapping the transporter-substrate interactions of the Trypanosoma cruzi NB1 nucleobase transporter reveals the basis for its high affinity and selectivity for hypoxanthine and guanine and lack of nucleoside uptake.

TcrNB1 Trypanosoma cruzi allopurinol hypoxanthine uptake kinetoplastid parasite nucleobase transporter

Journal

Molecular and biochemical parasitology
ISSN: 1872-9428
Titre abrégé: Mol Biochem Parasitol
Pays: Netherlands
ID NLM: 8006324

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 20 11 2023
revised: 19 02 2024
accepted: 20 02 2024
medline: 25 2 2024
pubmed: 25 2 2024
entrez: 24 2 2024
Statut: aheadofprint

Résumé

Trypanosoma cruzi is a protozoan parasite and the etiological agent of Chagas disease, a debilitating and sometimes fatal disease that continues to spread to new areas. Yet, Chagas disease is still only treated with two related nitro compounds that are insufficiently effective and cause severe side effects. Nucleotide metabolism is one of the known vulnerabilities of T. cruzi, as they are auxotrophic for purines, and nucleoside analogues have been shown to have genuine promise against this parasite in vitro and in vivo. Since purine antimetabolites require efficient uptake through transporters, we here report a detailed characterisation of the T. cruzi NB1 nucleobase transporter with the aim of elucidating the interactions between TcrNB1 and its substrates and finding the positions that can be altered in the design of novel antimetabolites without losing transportability. Systematically determining the inhibition constants (K

Identifiants

pubmed: 38401850
pii: S0166-6851(24)00009-4
doi: 10.1016/j.molbiopara.2024.111616
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111616

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mustafa M Aldfer (MM)

School of Infection and Immunity, Sir Graeme Davies Building, 120 University Place, University of Glasgow, Glasgow G12 8TA, UK.

Fabian Hulpia (F)

Laboratory for Medicinal Chemistry (Campus Heymans), Ghent University, Ottergemsesteenweg 460, 9000 Gent, Belgium; Laboratory for Medicinal Chemistry, Ghent University, Ghent, Belgium Present address: Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.

Serge van Calenbergh (S)

Laboratory for Medicinal Chemistry (Campus Heymans), Ghent University, Ottergemsesteenweg 460, 9000 Gent, Belgium.

Harry P De Koning (HP)

School of Infection and Immunity, Sir Graeme Davies Building, 120 University Place, University of Glasgow, Glasgow G12 8TA, UK. Electronic address: Harry.de-Koning@glasgow.ac.uk.

Classifications MeSH